North America's Pharma/Biotech Industry Enjoys Banner Year for Construction Projects

SUGAR LAND--December 28, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--The North American Pharmaceutical & Biotech Industry reported tremendous growth in capital construction during the 2021 calendar year. The COVID-19 pandemic brought the life science industry to the fore, driven by supply chain issues, the "reshoring" of production, the need for new therapeutics and research and development (R&D) spending, among other factors.